First National Bank of Mount Dora Trust Investment Services Boosts Holdings in HCA Healthcare, Inc. $HCA

First National Bank of Mount Dora Trust Investment Services increased its holdings in HCA Healthcare, Inc. (NYSE:HCA) by 0.8% during the second quarter, HoldingsChannel.com reports. The institutional investor owned 9,111 shares of the company’s stock after acquiring an additional 68 shares during the quarter. First National Bank of Mount Dora Trust Investment Services’ holdings in HCA Healthcare were worth $3,490,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds also recently made changes to their positions in HCA. Cheviot Value Management LLC purchased a new position in shares of HCA Healthcare in the first quarter worth approximately $26,000. Saudi Central Bank bought a new stake in HCA Healthcare during the 1st quarter worth approximately $26,000. WPG Advisers LLC bought a new stake in HCA Healthcare during the 1st quarter worth approximately $27,000. Ameriflex Group Inc. bought a new stake in HCA Healthcare during the 2nd quarter worth approximately $27,000. Finally, Chung Wu Investment Group LLC bought a new stake in HCA Healthcare during the 2nd quarter worth approximately $27,000. Hedge funds and other institutional investors own 62.73% of the company’s stock.

Insider Activity at HCA Healthcare

In other news, EVP Michael S. Cuffe sold 3,836 shares of the business’s stock in a transaction dated Monday, September 8th. The shares were sold at an average price of $418.84, for a total value of $1,606,670.24. Following the completion of the sale, the executive vice president owned 31,503 shares in the company, valued at approximately $13,194,716.52. The trade was a 10.85% decrease in their position. The transaction was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Corporate insiders own 1.30% of the company’s stock.

HCA Healthcare Stock Performance

Shares of HCA opened at $419.53 on Friday. The company’s fifty day moving average is $409.17 and its 200 day moving average is $377.66. HCA Healthcare, Inc. has a fifty-two week low of $289.98 and a fifty-two week high of $439.01. The stock has a market capitalization of $98.17 billion, a PE ratio of 17.63, a P/E/G ratio of 1.33 and a beta of 1.40.

HCA Healthcare (NYSE:HCA) last announced its quarterly earnings results on Friday, July 25th. The company reported $6.84 earnings per share for the quarter, topping the consensus estimate of $6.20 by $0.64. HCA Healthcare had a net margin of 8.21% and a negative return on equity of 7,363.11%. The company had revenue of $18.61 billion for the quarter, compared to analysts’ expectations of $18.49 billion. During the same quarter in the previous year, the business posted $5.50 earnings per share. HCA Healthcare’s quarterly revenue was up 6.4% on a year-over-year basis. HCA Healthcare has set its FY 2025 guidance at 25.500-27.000 EPS. As a group, research analysts forecast that HCA Healthcare, Inc. will post 24.98 earnings per share for the current year.

HCA Healthcare Announces Dividend

The firm also recently declared a quarterly dividend, which was paid on Tuesday, September 30th. Stockholders of record on Tuesday, September 16th were issued a $0.72 dividend. The ex-dividend date was Tuesday, September 16th. This represents a $2.88 annualized dividend and a dividend yield of 0.7%. HCA Healthcare’s payout ratio is currently 12.11%.

Analysts Set New Price Targets

HCA has been the topic of a number of recent analyst reports. KeyCorp raised their target price on shares of HCA Healthcare from $370.00 to $465.00 and gave the stock an “overweight” rating in a research note on Wednesday, October 8th. Robert W. Baird lifted their price objective on shares of HCA Healthcare from $380.00 to $423.00 and gave the company a “neutral” rating in a research report on Thursday, August 14th. Royal Bank Of Canada reduced their price objective on shares of HCA Healthcare from $404.00 to $401.00 and set an “outperform” rating on the stock in a research report on Monday, July 28th. UBS Group lifted their price objective on shares of HCA Healthcare from $438.00 to $495.00 and gave the company a “buy” rating in a research report on Tuesday. Finally, Barclays lifted their price objective on shares of HCA Healthcare from $390.00 to $445.00 and gave the company an “overweight” rating in a research report on Thursday, September 18th. One investment analyst has rated the stock with a Strong Buy rating, ten have assigned a Buy rating and nine have issued a Hold rating to the company’s stock. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and a consensus price target of $431.07.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.